Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Elisabetta Munzone

Director

European Institute of Oncology

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Articles (16)

Year:

2026

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (23)

Lukas Löfling

Senior Researcher - Epidemiology

Norwegian Veterinary Institute

NORWAY

View details

Sara Marceglia

Associate professor

University of Milan

ITALY

View details

patrizia boracchi

associate professor of medical statistics

University of Milan

ITALY

View details

Carmen Criscitiello

IRCCS Humanitas Research Hospital

ITALY

View details

Cameron Nowell

MONASH UNIVERSITY

AUSTRALIA

View details

Christos Sotiriou

Université libre de Bruxelles

BELGIUM

View details

Edoardo Crimini

Medical Oncologist

European Institute of Oncology

ITALY

View details

Alexandra Ziegler

MONASH UNIVERSITY

AUSTRALIA

View details

Lorenzo Ferrando

Assistant Professor

University of Genoa

ITALY

View details

Erica K. Sloan

Associate Professor

MONASH UNIVERSITY

AUSTRALIA

View details

Stewart Fabb

Senior Research Fellow

MONASH UNIVERSITY

AUSTRALIA

View details

Giuseppe Curigliano

European Institute of Oncology

ITALY

View details

Andrea Luigi Vitali

AI Governance-Ethic-Compliance Lead | Healthcare Research

Vita-Salute San Raffaele University

ITALY

View details

Nicla La Verde

Head of Department

ITALY

View details

Mariia Ivanova

Vita-Salute San Raffaele University

ITALY

View details

Gian Paolo Dagrada

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

ida paris

Head of Breast Oncology Unit

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

ITALY

View details

Federica Giugliano

Institut Gustave Roussy

FRANCE

View details

Luca Boscolo Bielo

European Institute of Oncology

ITALY

View details

Aeson Chang

Lecturer (Assistant Professor equivalent)

Monash University Malaysia.

AUSTRALIA

View details

Elia Mario Biganzoli

Full Professor Medical Statistics

University of Milan

ITALY

View details

Giampaolo Bianchini

Head Breast Cancer Group

IRCCS Ospedale San Raffaele

ITALY

View details

Nicoletta Staropoli

Ricercatori a tempo determinato

Magna Graecia University

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Elisabetta Munzone

Research Interests

Make your next move.

Explore related searches

Articles (16)

Interplay between HER2-Low status, hormone receptor expression, and therapeutic response to cyclin-dependent kinase 4/6 inhibitors as first-line treatment in luminal-like metastatic breast cancer: The CYCLHER study

Prognostic relation of body mass index on extended aromatase inhibition treatment in postmenopausal patients with estrogen receptor positive breast cancer: A retrospective analysis of the SOLE trial

The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy

Genomic and clinical landscape of metastatic hormone receptors-positive breast cancers carrying ESR1 alterations

Support for Chronic Pain Management for Breast Cancer Survivors Through Novel Digital Health Ecosystems: Pilot Usability Study of the PainRELife Mobile App

Development and Validation of a Natural Language Processing Algorithm for Extracting Clinical and Pathological Features of Breast Cancer From Pathology Reports

Correction: A Machine Learning Model to Predict Patients’ Adherence Behavior and a Decision Support System for Patients With Metastatic Breast Cancer: Protocol for a Randomized Controlled Trial

ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC).

Beta-blockade enhances anthracycline control of metastasis in triple-negative breast cancer

Unlocking the Resistance to Anti-HER2 Treatments in Breast Cancer: The Issue of HER2 Spatial Distribution

Usability Testing of a New Digital Integrated Health Ecosystem (PainRELife) for the Clinical Management of Chronic Pain in Patients With Early Breast Cancer: Protocol for a Pilot Study

Differential Benefit of Metronomic Chemotherapy Among Triple-Negative Breast Cancer Subtypes Treated in the IBCSG Trial 22–00

Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group

Risk-Based Therapeutic Strategies for HER2-Positive Early Breast Cancer: A Consensus Paper

A Machine Learning Model to Predict Patients’ Adherence Behavior and a Decision Support System for Patients With Metastatic Breast Cancer: Protocol for a Randomized Controlled Trial

A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy

Collaborators (23)

Lukas Löfling

Sara Marceglia

patrizia boracchi

Carmen Criscitiello

Cameron Nowell

Christos Sotiriou

Edoardo Crimini

Alexandra Ziegler

Lorenzo Ferrando

Erica K. Sloan

Stewart Fabb

Giuseppe Curigliano

Andrea Luigi Vitali

Nicla La Verde

Mariia Ivanova

Gian Paolo Dagrada

ida paris

Federica Giugliano

Luca Boscolo Bielo

Aeson Chang

Elia Mario Biganzoli

Giampaolo Bianchini

Nicoletta Staropoli

Make your next move.